Interval change in fractional exhaled nitric oxide (FENO) reflects short-term change in adherence following electronic inhaler reminders

BackgroundIn asthma, suppression of fractional exhaled nitric oxide (FENO) is a marker of adherence in the short-term. The usefulness of FENO to indicate change in adherence in the longer term is unknown.The aims of this study were to determine the relationship between changes in adherence and corresponding changes in FENO over short (1 week) and long-term (3 month) periods.MethodsAfter establishing initial ICS adherence using electronic inhaler monitor (EIM) devices, reminders were switched on for 1 week ('short-term') to optimize adherence. Reminders were then switched off and patients followed up after 3 months ('long-term'). FENO was measured at the start and end of each period. Using linear regression, we analyzed change in FENO in relation to change in adherence.ResultsForty-two patients contributed complete data for analysis. In the short-term, change in adherence was independently associated with change in FENO (β=-0.36, p = 0.036) even after adjusting for initial adherence and ICS dose. The higher the initial FENO, the greater the decline in FENO with improved adherence. This relationship between change in adherence and change in FENO was not observed in the long-term.ConclusionChange in adherence over 1 week following the use of EIM reminders independently predicted change in FENO. This relationship was not maintained at 3 months.

[1]  M. Hew,et al.  Electronic inhaler monitoring (EIM) for chronic airways disease: Development and application of a Multi-Dimensional Efficacy Framework. , 2021, The journal of allergy and clinical immunology. In practice.

[2]  H. Rupani,et al.  Using FeNO Measurement in Clinical Asthma Management. , 2021, Chest.

[3]  C. Janson,et al.  Importance of type and degree of IgE sensitisation for defining fractional exhaled nitric oxide reference values. , 2021, Respiratory medicine.

[4]  L. Kaye,et al.  Digital Assessment of Medication Utilization by Age and Diagnosis of Asthma or COPD. , 2020, The journal of allergy and clinical immunology. In practice.

[5]  S. Fowler,et al.  Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review , 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  P. Bradding,et al.  Clinical outcomes in people with difficult-to-control asthma using electronic monitoring to support medication adherence. , 2020, The journal of allergy and clinical immunology. In practice.

[7]  A. Bush,et al.  Electronic adherence monitoring identifies severe preschool wheezers who are steroid responsive , 2020, Pediatric pulmonology.

[8]  M. Mantero,et al.  Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry. , 2020, Respiratory medicine.

[9]  A. Nanzer,et al.  Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma , 2020, European Respiratory Journal.

[10]  M. Hew,et al.  Trajectory analyses of adherence patterns in a real-life moderate to severe asthma population. , 2019, The journal of allergy and clinical immunology. In practice.

[11]  R. Gerth van Wijk,et al.  Toward clinically applicable biomarkers for asthma: An EAACI position paper , 2019, Allergy.

[12]  R. Chaudhuri,et al.  Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label study , 2019, Thorax.

[13]  J. Virchow,et al.  Impact of an increase in the inhaled corticosteroid dose on blood eosinophils in asthma , 2018, Thorax.

[14]  O. Usmani,et al.  Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here? , 2018, The journal of allergy and clinical immunology. In practice.

[15]  T. Oguri,et al.  Combined measurements of fractional exhaled nitric oxide and nasal nitric oxide levels for assessing upper airway diseases in asthmatic patients , 2018, The Journal of asthma : official journal of the Association for the Care of Asthma.

[16]  L. Sharma,et al.  Relationship between total serum immunoglobulin E levels, fractional exhaled breath nitric oxide levels and absolute blood eosinophil counts in atopic and non-atopic asthma: a controlled comparative study , 2018, Journal of breath research.

[17]  P. Brand,et al.  Can exhaled nitric oxide fraction predict adherence to inhaled corticosteroids in atopic and nonatopic children with asthma? , 2017, The journal of allergy and clinical immunology. In practice.

[18]  C. Porsbjerg,et al.  Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study , 2016, Respiratory Research.

[19]  S. Hazen,et al.  Biomarker-based asthma phenotypes of corticosteroid response. , 2015, The Journal of allergy and clinical immunology.

[20]  R. Lutter,et al.  External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma , 2014, Thorax.

[21]  B. Lipworth,et al.  Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial. , 2012, Chest.

[22]  R. Naclerio,et al.  Criteria to screen for chronic sinonasal disease. , 2009, Chest.

[23]  P. Barnes,et al.  Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children , 2003, European Respiratory Journal.

[24]  P. Montuschi,et al.  Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma , 2002, Thorax.

[25]  M. Griese,et al.  Changes of exhaled nitric oxide during steroid treatment of childhood asthma , 1999, European Respiratory Journal.

[26]  Arthur S Slutsky,et al.  Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. , 2001, Chest.